CLC bio's read mapping algorithm beats popular open source alternatives in benchmarks

  CLC bio's read mapping algorithm beats popular open source alternatives in
  benchmarks

Business Wire

VIENNA -- October 10, 2012

Today at the Bio-IT World conference in Vienna, CLC bio officially released
the white paper on its new read mapping algorithm, which is included in the
current releases of CLC Genomics Workbench version 5.5 and CLC Genomics Server
version 4.5. The white paper covers four human datasets from the Illumina
GAII, Roche 454 Titanium, Life Technologies Ion Torrent PGM, and PacBioRS
platforms, and benchmarks CLC bio's read mapper for performance and accuracy
against the open source read mappers BWA, Bowtie2, and SMALT.

Highlights from the white paper include mapping of almost 99% of 1.34 billion
paired-end Illumina reads in 5 hours, compared to 28 hours and 99% for
Bowtie2, 41 hours and 96% for SMALT, and 60 hours and 95% for BWA. CLC bio's
new read mapper scales extremely well with multi-processor machines, enabling
up to 35-folddecreasein time to finish a read mapping, and delivers the
highest accuracy in almost all the benchmarks.

Program Director of World-wide Deep Computing in Life Sciences at IBM, Janis
E. Landry-Lane, states, "IBM has been productively engaged with CLC bio for
nearly two years. This collaboration has focused on optimizing the performance
of the CLC Assembly Cell de novo and reference mapping. We have achieved
remarkable results, and, I believe, performance of this order will be required
for the rigorous demands of genomics research. We look forward to serve our
customers together."

Bioinformatics Specialist at CLC bio, J.-Uwe Appelt, PhD, adds "PacBio is
popular for de novo projects, as its long reads are ideal for scaffolding and
currently BWA is considered the best open source read mapper for PacBio data.
However, this benchmark white paper proves that our new mapper, mapping 46% of
the reads correctly, outperforms BWA which got 5% correct and resulted in a
high false discovery rate. One of the reasons behind the strong performance of
our new read mapper is that it automatically adapts to arbitrary error-modes,
which means the users don't even have to tweak the parameter settings to get
the best results."

Download the white paper

Read an executive brief on the benchmarks and download the white paper here:

http://www.clcbio.com/link.php?id=298

About CLC bio

http://www.clcbio.com/about

Contact:

CLC bio
Lasse Görlitz, VP of Communications
Phone: +1 (617) 765-0687
E-mail: lgoerlitz@clcbio.com
 
Press spacebar to pause and continue. Press esc to stop.